Tech Company Financing Transactions
Viking Therapeutics Funding Round
Viking Therapeutics, based in San Diego, secured $2.5 million in funding from Ligand Pharmaceuticals.
Transaction Overview
Company Name
Announced On
5/28/2014
Transaction Type
Debt
Amount
$2,500,000
Round
Undisclosed
Investors
Ligand Pharmaceuticals (John Higgins)
Proceeds Purpose
Funds will be used to pay Viking's operating and financing-related expenses.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
12340 El Camino Real 250
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Viking Therapeutics (NASDAQ: VKTX) is focused on the development of novel therapeutics for patients suffering from metabolic and endocrine disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Lian
Chief Financial Officer
Michael Morneau
VP - Bus. Development
Amy Broidrick
VP - Bus. Development
Hiroko Masamune
VP - Finance
Gregory Zante
VP - Operations
Marianne Mancini
Browse more venture capital transactions:
Prev: 5/28/2014: SunFunder venture capital transaction
Next: 5/28/2014: MATRIXX Software venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs